Avoca, a WCG company

Webinar: Do You Have an Effective Oversight Plan of Your CRO-Vendor? How Are You Measuring It? ICH E6 R2 Requirements for Vendor Oversight

January 29, 2020 | 11:00am – 12:00pm EST
Sponsor Responsibilities for Quality Management (Section 5.0 of ICH E6 (R2)) requires that Sponsors oversee trial-related duties and functions, including those that are subcontracted by CROs (5.2.2). Quality assurance has changed from assurance of conformity to the assurance that process performance and quality are managed over […]

News Release: New Report Introduces Benchmarks on Clinical Trials Vendor Qualification Process

January 9, 2020 – GLOBE NEWSWIRE PRINCETON, NJ – A new report from Tufts Center for the Study of Drug Development establishes benchmarks for the vendor qualification process, a critical element of clinical trial set up and execution. According to its November/December Impact Report, the process volume and complexity of the vendor qualification process creates […]

Webinar: RBQM – The AQC’s Risk-Based Monitoring Framework and Monitoring Plans Consistent with New FDA Draft Guidance

December 11, 2019 | 11:00am-12:00pm EST
RBQM: The AQC’s Risk-Based Monitoring Framework and Monitoring Plans Consistent with New FDA Draft Guidance

Virtual Clinical Trials Conference

December 2-3, 2019 | Sonesta Hotel | Philadelphia, PA Virtual clinical trials bring the clinical trial experience to the patient. Through these VCTs, companies are expected to reduce trial costs and increase patient enrollment and participation. There are new technologies that make these trials easier to conduct and with the patient demand for more flexibility in their participation, this new way of doing business will only continue to expand for the industry. […]

News Release: New Study from Tufts Center for the Study of Drug Development Establishes Benchmarks for Vendor Qualification Process

November 14, 2019 - Tufts CSDD Study Identifies Opportunities for Drug Sponsors to Optimize Vendor Selection

Article: The Spirit of Radical Integration

November 2019 In the Spotlight article published November 2019 by International Clinical Trials, Patricia (Patty) Leuchten, Founder and CEO of The Avoca Group, reflects on the challenges associated with managing risks and designing quality into clinical trials; the work the Avoca Quality Consortium® has done to bring together industry experts from pharma, biotech, and CROs […]

8th Annual AQC Fall Member Meeting

November 7, 2019 | Seattle, WA
Attendance at the Fall Member Meeting is one of many benefits of Membership of the Avoca Quality Consortium. Participants gain practical knowledge and experience in a casual, interactive learning environment.

Webinar: Managing Risk and Oversight in Decentralized Clinical Trials Using Industry Standards

October 30, 2019 | 11:00am – 12:00pm EDT
In this webinar, Dennis Salotti, Chief Operating Officer of The Avoca Group, will present the current state of industry adoption of technologies enabling decentralized clinical trials and discuss perceptions of the challenges, risks, opportunities, and impact as captured by Avoca’s 2018 industry research into this topic. […]

« Older posts

Newer posts »

News & Events